Andrew Callos, EVP, Chief Commercial Officer at CYTOKINETICS INC (CYTK), sold 5,772 shares at $35.78 ($207K) on 2025-04-07, disclosed to the SEC on 2025-04-07.
Scheduled sale ($207k) by EVP, Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.78 | 2,886 | $103K | 50.0% |
| 2 | $35.78 | 2,886 | $103K | 50.0% |
| Total | $35.78 avg | 5,772 | $207K | 100% |
| Filing → |
| CYTK | SELL | 2026-07-02 | $1.3M | — | Filing → |
| CYTK | SELL | 2026-06-01 | $1.1M | — | Filing → |
| CYTK | SELL | 2026-05-05 | $875K | — | Filing → |